| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |